Stimulation of FcγRI on primary sensory neurons increases insulin-like growth factor-I production, thereby reducing reperfusion-induced renal injury in mice

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 1303-1310

  Harada, Naoaki ^a   Zhao, Juan ^a   Kurihara, Hiroki ^b   Nakagata, Naomi ^c   Okajima, Kenji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOPHENYLACYL BROMIDE; 4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; CALCITONIN GENE RELATED PEPTIDE; CASPASE 3; CD64 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; KT 5710; PHOSPHOLIPASE A2 INHIBITOR; SOMATOMEDIN C; UNCLASSIFIED DRUG; 4 BROMOPHENACYL BROMIDE; 4-BROMOPHENACYL BROMIDE; ACETOPHENONE DERIVATIVE; ANTIBODY; CARBAZOLE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FC RECEPTOR; FCGR1 PROTEIN, MOUSE; KT 5720; PHOSPHOLIPASE A2; PYRROLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOSTIMULATION; KIDNEY DENERVATION; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY TUBULE; KNOCKOUT MOUSE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SENSORY NERVE CELL; SPINAL GANGLION; TISSUE LEVEL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; SENSORY RECEPTOR; VASCULARIZATION;

ACETOPHENONES; ANIMALS; ANTIBODIES; APOPTOSIS; CALCITONIN GENE-RELATED PEPTIDE; CARBAZOLES; CASPASE 3; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; PHOSPHOLIPASES A2; PYRROLES; RECEPTORS, IGG; REPERFUSION INJURY; SENSORY RECEPTOR CELLS;

EID: 77955477832     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902051     Document Type: Article

References (37)

1. Casadevall, A., E. Dadachova, and L. A. Pirofski. 2004. Passive antibody therapy for infectious diseases. Nat. Rev. Microbiol. 2: 695-703.
2. Wallace, P. K., A. L. Howell, and M. W. Fanger. 1994. Role of Fc gamma receptors in cancer and infectious disease. J. Leukoc. Biol. 55: 816-826.
3. Ravetch, J. V. 1994. Fc receptors: rubor redux. Cell 78: 553-560.
4. Hulett, M. D., and P. M. Hogarth. 1994. Molecular basis of Fc receptor function. Adv. Immunol. 57: 1-127.
5. Andoh, T., and Y. Kuraishi. 2004. Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I. FASEB J. 18: 182-184.
6. Maggi, C. A., and A. Meli. 1988. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen. Pharmacol. 19: 1-43.
7. Dray, A. 1995. Inflammatory mediators of pain. Br. J. Anaesth. 75: 125-131.
8. Rosenfeld, M. G., J. J. Mermod, S. G. Amara, L. W. Swanson, P. E. Sawchenko, J. Rivier, W. W. Vale, and R. M. Evans. 1983. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304: 129-135.
9. Dobolyi, A., S. Irwin, G. Makara, T. B. Usdin, and M. Palkovits. 2005. Calcitonin gene-related peptide-containing pathways in the rat forebrain. J. Comp. Neurol. 489: 92-119.
10. van Rossum, D., U. K. Hanisch, and R. Quirion. 1997. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev. 21: 649-678.
11. Harada, N., K. Okajima, H. Kurihara, and N. Nakagata. 2007. Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I, thereby reducing reperfusion-induced apoptosis in mice. Neuropharmacology 52: 1303-1311. (Pubitemid 46527704)
12. Daughaday, W. H., and P. Rotwein. 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10: 68-91.
13. Carroll, P. V. 2001. Treatment with growth hormone and insulin-like growth factor-I in critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 15: 435-451.
14. Harada, N., K. Okajima, and H. Isobe. 2008. Role of neutrophil elastase in development of pulmonary vascular injury and septic shock in rats. Shock 30: 379-387.
15. Kushimoto, S., K. Okajima, H. Okabe, and B. R. Binder. 1996. Role of granulocyte elastase in the formation of hemorrhagic shock-induced gastric mucosal lesions in the rat. Crit. Care Med. 24: 1041-1046.
16. Mizutani, A., K. Okajima, M. Uchiba, H. Isobe, N. Harada, S. Mizutani, and T. Noguchi. 2003. Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 101: 3029-3036. (Pubitemid 36857991)
17. Okajima, K., N. Harada, M. Uchiba, and M. Mori. 2004. Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1116-G1123.
18. Zhao, J., N. Harada, K. Sobue, H. Katsuya, and K. Okajima. 2009. Insulin-like growth factor-I reduces stress-induced gastric mucosal injury by inhibiting neutrophil activation in mice. Growth Horm. IGF Res. 19: 136-145.
19. Oh-hashi, Y., T. Shindo, Y. Kurihara, T. Imai, Y. Wang, H. Morita, Y. Imai, Y. Kayaba, H. Nishimatsu, Y. Suematsu, et al. 2001. Elevated sympathetic nervous activity in mice deficient in alphaCGRP. Circ. Res. 89: 983-990.
20. Harada, N., K. Okajima, M. Uchiba, H. Kurihara, and N. Nakagata. 2006. Antithrombin reduces reperfusion-induced liver injury in mice by enhancing sensory neuron activation. Thromb. Haemost. 95: 788-795.
21. Evans, R. J., and A. Surprenant. 1993. Effects of phospholipase A2 inhibitors on coupling of alpha 2-adrenoceptors to inwardly rectifying potassium currents in guinea-pig submucosal neurones. Br. J. Pharmacol. 110: 591-596.
22. Nakayama, T., N. Harada, M. Asano, N. Nomura, T. Saito, A. Mishima, and K. Okajima. 2007. Atrial natriuretic peptide reduces ischemia/reperfusion- induced spinal cord injury in rats by enhancing sensory neuron activation. J. Pharmacol. Exp. Ther. 322: 582-590.
23. Tognetto, M., S. Amadesi, S. Harrison, C. Creminon, M. Trevisani, M. Carreras, M. Matera, P. Geppetti, and A. Bianchi. 2001. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J. Neurosci. 21: 1104-1109. (Pubitemid 32128755)
24. Mohapatra, D. P., and C. Nau. 2003. Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J. Biol. Chem. 278: 50080-50090.
25. Hou, L., and X. Wang. 2001. PKC and PKA, but not PKG mediate LPS-induced CGRP release and [Ca(2+)](i) elevation in DRG neurons of neonatal rats. J. Neurosci. Res. 66: 592-600.
26. De Vries, B., R. A. Matthijsen, T. G. Wolfs, A. A. Van Bijnen, P. Heeringa, and W. A. Buurman. 2003. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 75: 375-382.
27. Buck, S. H., and T. F. Burks. 1986. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol. Rev. 38: 179-226.
28. Narimatsu, N., N. Harada, H. Kurihara, N. Nakagata, K. Sobue, and K. Okajima. 2009. Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus. J. Pharmacol. Exp. Ther. 330: 2-12.
29. Harada, N., K. Okajima, H. Kurihara, and N. Nakagata. 2008. Antithrombin prevents reperfusion-induced hepatic apoptosis by enhancing insulin-like growth factor-I production in mice. Crit. Care Med. 36: 971-974.
30. Kunduzova, O. R., G. Escourrou, M. H. Seguelas, P. Delagrange, F. De La Farge, C. Cambon, and A. Parini. 2003. Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J. 17: 872-874.
31. Schnizler, K., L. P. Shutov, M. J. Van Kanegan, M. A. Merrill, B. Nichols, G. S. McKnight, S. Strack, J.W. Hell, and Y. M. Usachev. 2008. Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J. Neurosci. 28: 4904-4917.
32. Park, K. A., and M. R. Vasko. 2005. Lipid mediators of sensitivity in sensory neurons. Trends Pharmacol. Sci. 26: 571-577.
33. Zheng, L., T. P. Zomerdijk, M. T. Van Den Barselaar, M. F. Geertsma, R. Van Furth, and P. H. Nibbering. 1999. Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intracellular killing of Staphylococcus aureus by human monocytes. Immunology 96: 90-97.
34. Suh, Y. G., and U. Oh. 2005. Activation and activators of TRPV1 and their pharmaceutical implication. Curr. Pharm. Des. 11: 2687-2698.
35. Price, T. J., A. Patwardhan, A. N. Akopian, K. M. Hargreaves, and C. M. Flores. 2004. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br. J. Pharmacol. 141: 1118-1130.
36. Mejía-Vilet, J.M., V. Ramírez, C. Cruz, N. Uribe, G. Gamba, and N. A. Bobadilla. 2007. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am. J. Physiol. Renal Physiol. 293: F78-F86.
37. Remick, D. G. 2007. Pathophysiology of sepsis. Am. J. Pathol. 170: 1435-1444.